Purchases and Sales Made in Q4 2023 in Kezar Life Sciences, Inc. (KZR)
This table provides information about the institutional ownership of Kezar Life Sciences, Inc. (KZR) during Q4 2023. The information is specifically focused on institutions that hold shares of Kezar Life Sciences, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 18, 2024
Q4 2023
|
Cutler Group LP
|
SELL
|
- |
-5.3K- 68.83% |
$3.82K - $6.09K
|
2.4K
$15.6K
|
|
|
Jan 31, 2024
Q4 2023
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-7.19K- 26.04% |
$5.18K - $8.27K
|
20.4K
$133K
|
|
|
Feb 14, 2024
Q4 2023
|
Alliancebernstein L.P.
New York, NY |
SELL
|
- |
-8.6K- 9.81% |
$6.19K - $9.89K
|
79.1K
$515K
|
|
|
Feb 02, 2024
Q4 2023
|
Simplex Trading, LLC
|
SELL
|
- |
-10.5K- 75.45% |
$7.59K - $12.1K
|
3.43K
$22.3K
|
|
|
Feb 13, 2024
Q4 2023
|
Prudential Financial Inc
Newark, NJ |
SELL
|
- |
-17.6K- 48.04% |
$12.6K - $20.2K
|
19K
$124K
|
|
|
Feb 09, 2024
Q4 2023
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-20.7K- 17.74% |
$14.9K - $23.8K
|
95.8K
$624K
|
|
|
Feb 13, 2024
Q4 2023
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-26.3K- 4.62% |
$19K - $30.3K
|
543K
$3.54M
|
|
|
Feb 13, 2024
Q4 2023
|
Xtx Topco LTD
London, X0 |
SELL
|
- |
-27.7K- 38.59% |
$19.9K - $31.8K
|
44K
$287K
|
|
|
Feb 06, 2024
Q4 2023
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-119K- 34.43% |
$85.6K - $137K
|
226K
$1.47M
|
|
|
Feb 13, 2024
Q4 2023
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-135K- 2.73% |
$97.2K - $155K
|
4.82M
$31.4M
|
|
|
Feb 14, 2024
Q4 2023
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-152K- 48.86% |
$109K - $174K
|
159K
$1.03M
|
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-814K- 21.75% |
$586K - $936K
|
2.93M
$19.1M
|
|
|
Feb 12, 2024
Q4 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-912K- 95.17% |
$657K - $1.05M
|
46.3K
$301K
|
|
|
Feb 13, 2024
Q4 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-942K- 68.03% |
$678K - $1.08M
|
443K
$2.88M
|
|
|
Feb 14, 2024
Q4 2023
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-986K- 16.4% |
$710K - $1.13M
|
5.03M
$32.7M
|
|
|
Feb 14, 2024
Q4 2023
|
Prosight Management, LP
Dallas, TX |
SELL
|
- |
-1.41M- 29.46% |
$1.01M - $1.62M
|
3.37M
$21.9M
|
|
|
Feb 14, 2024
Q4 2023
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-3.54M- 64.73% |
$2.55M - $4.07M
|
1.93M
$12.5M
|